A treatment that is used in very few Latin American countries and that orally less than ten countries in the world administer it, is in Costa Rica, a formula that is managing to change the life prognosis of patients suffering from promyelocytic leukemia.
Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells.
In Acute Promyelocytic Leukemia (APL), immature white blood cells called promyelocytes accumulate in the bone marrow. APL is a subtype of acute myeloid leukemia (AML). The symptoms tend to be similar to AML.
According to Dr. Willem Buján, a specialist in Hematology at Hospital México, to date they have managed to treat seven patients with APL, obtaining a 100% positive response to treatment, and which